Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseModulation of host adaptive immunity by hRSV proteinsType I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection.Expansion, maintenance, and memory in NK and T cells during viral infections: responding to pressures for defense and regulation.A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsSendai virus-based RSV vaccine protects African green monkeys from RSV infection.Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune CellsPre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.Cell-mediated immune responses to respiratory syncytial virus infection: magnitude, kinetics, and correlates with morbidity and agePrevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention.The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.Respiratory syncytial virus: current progress in vaccine development.Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease.Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.Respiratory syncytial virus vaccine development
P2860
Q26775152-AF8ACA34-DA07-436C-A54A-A005118705D3Q27022693-5F2E325B-297A-4171-BAA6-61880431456AQ30275794-2511449D-8B62-47F1-8BF1-2E1DC78D6313Q33548803-D8C1079E-DDA8-43D6-93A3-4BC305A2E246Q33578748-65EB44CF-0F95-4AB5-93A4-A483B7B6D24CQ34504791-19BF5FBA-FDFC-4BFC-9087-CA924B7C33C2Q35566601-36D9A64E-A33D-4238-8830-82BDE8F2C990Q35667184-E7EC1327-BFEC-463A-99E8-7E9F02C1A58EQ35808047-96A4C9C8-082E-44DF-B1F6-8D2CE9B3FDACQ36301296-DDE5CB61-2ADD-448B-87F1-3D02014E22E4Q36667922-6FE899DD-3F57-4FE2-8722-9FE6ECFDC495Q36977881-364E1D11-F3CB-4F0C-B95C-604D66903725Q37841269-0619BF13-ED08-4959-8D7B-9D0D9B5C3884Q38068469-5237D563-A2CC-40F6-8979-CC622E18D0F9Q38079432-7F951275-20F0-497C-92D6-3CEF14655AE9Q38998557-525EBD72-1AAB-40D9-BE4B-3E43252B86A3Q39007664-D7587644-A734-482B-8DBB-4A810C0DC0CFQ47553316-50C857DA-6679-45BD-B8D8-47120E27AB72Q56893551-70F6EF5A-64F8-4E6F-8E97-DAFC2729D59E
P2860
Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pulmonary eosinophilia is atte ...... RSV vaccine-enhanced disease.
@ast
Pulmonary eosinophilia is atte ...... RSV vaccine-enhanced disease.
@en
type
label
Pulmonary eosinophilia is atte ...... RSV vaccine-enhanced disease.
@ast
Pulmonary eosinophilia is atte ...... RSV vaccine-enhanced disease.
@en
altLabel
Pulmonary eosinophilia is atte ...... f RSV vaccine-enhanced disease
@en
prefLabel
Pulmonary eosinophilia is atte ...... RSV vaccine-enhanced disease.
@ast
Pulmonary eosinophilia is atte ...... RSV vaccine-enhanced disease.
@en
P2093
P2860
P921
P356
P1433
P1476
Pulmonary eosinophilia is atte ...... RSV vaccine-enhanced disease.
@en
P2093
Jonathan P Castillo
Whitney W Stevens
P2860
P304
P356
10.1089/VIM.2009.0016
P407
P577
2009-07-01T00:00:00Z